Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Renaud

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Opinion in Pharmacology|July 8, 2009
Biophysical techniques for ligand screening and drug designJean-Paul Renaud, Marc-André Delsuc
Journal of Chemical Information and Modeling|March 30, 2013
In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLELaurent Hoffer, Jean-Paul Renaud, Dragos Horvath
Combinatorial Chemistry & High Throughput Screening|April 28, 2011
Fragment-based drug design: computational & experimental state of the artLaurent Hoffer, Jean-Paul Renaud, Dragos Horvath
The Journal of Biological Chemistry|May 27, 2004
Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivityHolger Greschik, Ralf Flaig, Jean-Paul Renaud, et al.
Database : the Journal of Biological Databases and Curation|October 12, 2024
StopKB: a comprehensive knowledgebase for nonsense suppression therapiesNicolas Haas, Julie Dawn Thompson, Jean-Paul Renaud, et al.
Biochemical and Biophysical Research Communications|November 25, 2003
Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopyDmitri R Davydov, James R Halpert, Jean-Paul Renaud, et al.
Human Molecular Genetics|April 18, 2003
Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patientsSylvia G Lehmann, Jean-Marie Wurtz, Jean-Paul Renaud, et al.
Nature Reviews. Drug Discovery|June 9, 2018
Cryo-EM in drug discovery: achievements, limitations and prospectsJean-Paul Renaud, Ashwin Chari, Claudio Ciferri, et al.
Molecular Cell|February 28, 2002
Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3Holger Greschik, Jean-Marie Wurtz, Sarah Sanglier, et al.
Protein Science : a Publication of the Protein Society|March 22, 2003
Using nondenaturing mass spectrometry to detect fortuitous ligands in orphan nuclear receptorsNoelle Potier, Isabelle M L Billas, Anke Steinmetz, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Opinion in Pharmacology|July 8, 2009
Biophysical techniques for ligand screening and drug designJean-Paul Renaud, Marc-André Delsuc
Journal of Chemical Information and Modeling|March 30, 2013
In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLELaurent Hoffer, Jean-Paul Renaud, Dragos Horvath
Combinatorial Chemistry & High Throughput Screening|April 28, 2011
Fragment-based drug design: computational & experimental state of the artLaurent Hoffer, Jean-Paul Renaud, Dragos Horvath
The Journal of Biological Chemistry|May 27, 2004
Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivityHolger Greschik, Ralf Flaig, Jean-Paul Renaud, et al.
Database : the Journal of Biological Databases and Curation|October 12, 2024
StopKB: a comprehensive knowledgebase for nonsense suppression therapiesNicolas Haas, Julie Dawn Thompson, Jean-Paul Renaud, et al.
Biochemical and Biophysical Research Communications|November 25, 2003
Conformational heterogeneity of cytochrome P450 3A4 revealed by high pressure spectroscopyDmitri R Davydov, James R Halpert, Jean-Paul Renaud, et al.
Human Molecular Genetics|April 18, 2003
Structure-function analysis reveals the molecular determinants of the impaired biological function of DAX-1 mutants in AHC patientsSylvia G Lehmann, Jean-Marie Wurtz, Jean-Paul Renaud, et al.
Nature Reviews. Drug Discovery|June 9, 2018
Cryo-EM in drug discovery: achievements, limitations and prospectsJean-Paul Renaud, Ashwin Chari, Claudio Ciferri, et al.
Molecular Cell|February 28, 2002
Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3Holger Greschik, Jean-Marie Wurtz, Sarah Sanglier, et al.
Protein Science : a Publication of the Protein Society|March 22, 2003
Using nondenaturing mass spectrometry to detect fortuitous ligands in orphan nuclear receptorsNoelle Potier, Isabelle M L Billas, Anke Steinmetz, et al.
Pageof 2